Age as a moderating factor of treatment resistance in depression.
antidepressant
sold age
treatment-resistant depression
Journal
European psychiatry : the journal of the Association of European Psychiatrists
ISSN: 1778-3585
Titre abrégé: Eur Psychiatry
Pays: England
ID NLM: 9111820
Informations de publication
Date de publication:
20 04 2023
20 04 2023
Historique:
medline:
9
5
2023
pubmed:
20
4
2023
entrez:
20
04
2023
Statut:
epublish
Résumé
Treatment-resistant depression (TRD) is an important clinical challenge and may present differently between age groups. A total of 893 depressed patients recruited within the framework of the European research consortium "Group for the Studies of Resistant Depression" were assessed by generalized linear models regarding age effects (both as numerical and factorial predictors) on treatment outcome, number of lifetime depressive episodes, hospitalization time, and duration of the current episode. Effects of age as numerical predictor on the severity of common depressive symptoms, measured with Montgomery-Åsberg Depression Rating Scale (MADRS) for two-time points, were assessed by linear mixed models, respectively, for patients showing TRD and treatment response. A corrected Overall symptom load reflected by MADRS ( In this naturalistic sample of severely ill depressed patients, antidepressant treatment protocols were equally effective in addressing TRD in old age. However, specific symptoms such as sadness, appetite, and concentration showed an age-dependent presentation, impacting residual symptoms in severely affected TRD patients and calling for a precision approach by a better integration of age profiles in treatment recommendations.
Sections du résumé
BACKGROUND
Treatment-resistant depression (TRD) is an important clinical challenge and may present differently between age groups.
METHODS
A total of 893 depressed patients recruited within the framework of the European research consortium "Group for the Studies of Resistant Depression" were assessed by generalized linear models regarding age effects (both as numerical and factorial predictors) on treatment outcome, number of lifetime depressive episodes, hospitalization time, and duration of the current episode. Effects of age as numerical predictor on the severity of common depressive symptoms, measured with Montgomery-Åsberg Depression Rating Scale (MADRS) for two-time points, were assessed by linear mixed models, respectively, for patients showing TRD and treatment response. A corrected
RESULTS
Overall symptom load reflected by MADRS (
CONCLUSIONS
In this naturalistic sample of severely ill depressed patients, antidepressant treatment protocols were equally effective in addressing TRD in old age. However, specific symptoms such as sadness, appetite, and concentration showed an age-dependent presentation, impacting residual symptoms in severely affected TRD patients and calling for a precision approach by a better integration of age profiles in treatment recommendations.
Identifiants
pubmed: 37078509
doi: 10.1192/j.eurpsy.2023.17
pii: S0924933823000172
pmc: PMC10228354
doi:
Substances chimiques
Antidepressive Agents
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e35Références
Chest. 2011 Jul;140(1):16-18
pubmed: 21729890
Am J Psychiatry. 2005 Apr;162(4):691-8
pubmed: 15800140
Psychiatry Res. 2016 Jun 30;240:421-430
pubmed: 27155594
World J Biol Psychiatry. 2019 Jul;20(6):427-448
pubmed: 31340696
Acta Psychiatr Scand. 2018 May;137(5):401-412
pubmed: 29492960
Psychol Med. 2010 Feb;40(2):225-37
pubmed: 19531277
J Affect Disord. 2018 Aug 1;235:362-367
pubmed: 29665520
Curr Neuropharmacol. 2015;13(5):577-91
pubmed: 26467408
Am J Geriatr Psychiatry. 2020 Feb;28(2):121-141
pubmed: 31734084
Int J Geriatr Psychiatry. 2010 Oct;25(10):981-7
pubmed: 19998316
Depress Anxiety. 2021 Sep;38(9):896-906
pubmed: 34110066
Pharmacopsychiatry. 2010 Aug;43(6):210-5
pubmed: 20589597
J Affect Disord. 2001 Oct;66(2-3):225-36
pubmed: 11578676
Drugs Aging. 2004;21(8):531-54
pubmed: 15182217
Eur J Clin Pharmacol. 2017 Jun;73(6):661-667
pubmed: 28280892
J Clin Psychiatry. 2011 Dec;72(12):1660-8
pubmed: 22244025
BMC Psychiatry. 2015 Feb 12;15:20
pubmed: 25775143
Can J Psychiatry. 2010 Mar;55(3):126-35
pubmed: 20370962
Clin Geriatr Med. 2014 Aug;30(3):517-34
pubmed: 25037293
Aging Clin Exp Res. 2010 Apr;22(2):100-15
pubmed: 20440097
Clin Interv Aging. 2016 Sep 09;11:1193-1198
pubmed: 27672315
Eur Neuropsychopharmacol. 1999 Jan;9(1-2):83-91
pubmed: 10082232
J Geriatr Psychiatry Neurol. 1998 Winter;11(4):186-93
pubmed: 10230997
Lancet. 2016 Oct 8;388(10053):1545-1602
pubmed: 27733282
Int J Geriatr Psychiatry. 2002 Jan;17(1):65-72
pubmed: 11802233
J Psychiatr Res. 2019 Sep;116:178-184
pubmed: 30878146
Encephale. 2006 Oct;32(5 Pt 1):781-8
pubmed: 17099603
Psychol Med. 1999 Mar;29(2):325-39
pubmed: 10218924
J Affect Disord. 2016 Jan 1;189:224-32
pubmed: 26451508
JAMA Psychiatry. 2022 Mar 01;79(3):210-218
pubmed: 35080618
Eur Neuropsychopharmacol. 2012 Jul;22(7):453-68
pubmed: 22464339
Annu Rev Public Health. 2013;34:119-38
pubmed: 23514317
J Clin Psychiatry. 2017 Feb;78(2):215-222
pubmed: 28068461
Dialogues Clin Neurosci. 2008;10(4):419-30
pubmed: 19170399
Annu Rev Clin Psychol. 2009;5:363-89
pubmed: 19327033
Fam Pract. 2007 Apr;24(2):168-80
pubmed: 17237495
Compr Psychiatry. 2015 Jan;56:85-92
pubmed: 25459419
J Clin Psychiatry. 2018 Jan/Feb;79(1):
pubmed: 29228516
Lancet. 2005 Jun 4-10;365(9475):1961-70
pubmed: 15936426
J Affect Disord. 2017 Jan 15;208:191-197
pubmed: 27792962
J Affect Disord. 1997 Dec;46(3):163-73
pubmed: 9547114
J Affect Disord. 2012 Dec 10;141(2-3):103-15
pubmed: 22480823
Age (Dordr). 2013 Dec;35(6):2357-66
pubmed: 23354682
Sleep Disord. 2014;2014:843126
pubmed: 24955254
Int Psychogeriatr. 1995;7 Suppl:83-94
pubmed: 8580395
Acta Psychiatr Scand. 2019 Jan;139(1):78-88
pubmed: 30291625
J Gerontol. 1994 Nov;49(6):P251-64
pubmed: 7963280
J Gerontol. 1991 Sep;46(5):P224-35
pubmed: 1890289
J Am Geriatr Soc. 1997 May;45(5):570-8
pubmed: 9158577
J Affect Disord. 2004 May;80(1):87-93
pubmed: 15094262
Am J Geriatr Psychiatry. 2014 May;22(5):437-41
pubmed: 23567374